Avidity Biosciences Announces Upcoming Presentations at the American Academy of Neurology 2022 Annual Meeting
/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody...
San Diego United States Kath Gallagher Rna Optimization For The Development Company Contact Prnewswire Avidity Biosciences Inc
Source: prnewswire.com